RMD · Resmed Inc
United States · RS rating 63 · As of 2026-11-03
| Price | 227.08 USD |
|---|---|
| 1-day change | -2.5% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 63 / 70 / 45 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 33 / 23 / 36 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +13.1% |
| Sales growth Q/Q | +6.5% |
| Distance from 52-week high | +17.7% |
| Market cap (USD) | $32.0B |